AI assistant
Sending…
BioInvent International — Major Shareholding Notification 2016
Dec 30, 2016
3011_iss_2016-12-30_9433f73a-d2ce-48af-9189-bed6c6f18ff5.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Issuer BioInvent International Aktiebolag
Holder
Pfizer Strategic Investment Holdings LLC
Instrument
| Instrument | Aktie |
|---|---|
| Before the transaction | |
| Shares | 0 |
| Voting rights | 0 |
| Transaction | |
| Reason for major shareholding notification New share issue | |
| Date | 28/12/2016 |
| Limit for number of shares | 5 % |
| Limit for number of votes | 5 % |
| After the transaction | |
| Quantity | |
| Shares | 21,973,594 |
| Directly held voting rights | 21,973,594 |
| Indirectly held voting rights | 0 |
| Percentage | |
| Directly held shares | 7.21 % |
| Directly held voting rights | 7.21 % |
| Indirectly held voting rights | 0 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
||
|---|---|---|---|
| Shares | 7.21 % | 21,973,594 | |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 Instruments - FITA Ch. 4, section 2, first paragraph, line 3 - Physically settled - Cash settled |
|||
| Total | 7.21 % | 21,973,594 | |
| Notes (other relevant informations according to law) Korrigering kontaktperson. |
|||
| Published 30/12/2016 10:22 |
Contact Name Erik Ellenius Phone +46703483855 Email [email protected]
CLOSE PRINT
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from BioInvent International
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 21
Declaration of Voting Results & Voting Rights Announcements
2026
Apr 29
AGM Information
2026
Apr 29
Interim / Quarterly Report
2026
Apr 29
Interim / Quarterly Report
2026
Apr 29
Annual Report
2026
Mar 31
Proxy Solicitation & Information Statement
2026
Mar 24
Proxy Solicitation & Information Statement
2026
Mar 24
Interim / Quarterly Report
2026
Feb 26